Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries. The Company's Human Nutrition & Health segment offers creamer systems, dairy replacers, powdered fats, cereals, and human grade choline nutrients and mineral amino acid chelated products for wellness applications. Its Animal Nutrition & Health segment provides microencapsulated products, chelation technology, and choline chloride. The Specialty Products segment offers ethylene oxide and single use canisters with ethylene oxide for sterilizing re-usable devices. It also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as sells chelated minerals for high value crops. The Company's Industrial Products segment provides derivatives of choline chloride for use in industrial applications, and methylamines.

Type
Public
HQ
New Hampton, US
Founded
1967
Size (employees)
1,060 (est)
Balchem Corporation was founded in 1967 and is headquartered in New Hampton, US
Report incorrect company information

Key People/Management at Balchem Corporation

Ted Harris

Ted Harris

Chairman and Chief Executive Officer
Mark Stach

Mark Stach

General Counsel
William Backus

William Backus

Chief Accounting Officer and Treasurer
Mike Size

Mike Size

Vice President/General Manager Ingredient Solutions
Jim Hyde

Jim Hyde

Vice President/General Manager Human Nutrition and Pharma
Ria Dake

Ria Dake

General Manager Cereal Systems
Show more

Balchem Corporation Office Locations

Balchem Corporation has offices in Lincoln, Chicago, Salt Lake City, Covington and in 6 other locations
New Hampton, US (HQ)
52 Sunrise Park Rd
Show all (10)
Report incorrect company information

Balchem Corporation Financials and Metrics

Balchem Corporation Financials

Balchem Corporation's revenue was reported to be $594.79 m in FY, 2017
USD

Revenue (FY, 2017)

594.8 m

Gross profit (FY, 2017)

189 m

Gross profit margin (FY, 2017), %

31.8%

Net income (FY, 2017)

90.1 m

Market capitalization (20-Apr-2018)

2.9 b

Cash (31-Dec-2017)

40.4 m

EV

3 b
Balchem Corporation's current market capitalization is $2.9 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

337.2 m541.4 m552.5 m553.2 m594.8 m

Revenue growth, %

61%2%0%

Cost of goods sold

239.8 m397.2 m384.4 m372.3 m405.8 m

Gross profit

97.4 m144.2 m168.1 m180.9 m189 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

87.6 m86 m132.2 m160.5 m144.9 m134.8 m140.1 m135.1 m138.8 m138.5 m137.7 m147.1 m

Cost of goods sold

63.1 m62.8 m99.9 m116 m101.7 m92.9 m97 m92.3 m92.3 m93.9 m93.3 m100.3 m

Gross profit

24.5 m23.2 m32.3 m44.5 m43.1 m41.9 m43.2 m42.8 m46.4 m44.7 m44.4 m46.8 m

Gross profit Margin, %

28%27%24%28%30%31%31%32%33%32%32%32%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

208.7 m50.3 m84.8 m38.6 m40.4 m

Inventories

24.8 m49.6 m46.1 m57.2 m60.7 m

Current Assets

277.8 m181.3 m198.8 m188.4 m199.3 m

PP&E

54.9 m131.6 m158.5 m165.8 m189.8 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

190.2 m207.3 m59.7 m25.4 m56.6 m72.2 m81.6 m39.2 m33.4 m32.5 m37 m43.6 m

Accounts Receivable

40.5 m

Inventories

24.7 m24.9 m57 m58.2 m50.5 m47.9 m50.7 m60.4 m57.8 m56.7 m62.9 m62.1 m

Current Assets

258.5 m284.9 m199.3 m163.8 m179.1 m193.5 m204.1 m177.5 m169 m172.8 m187 m201.8 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

44.9 m52.8 m59.7 m56 m90.1 m

Depreciation and Amortization

10.5 m30.5 m40 m46.2 m44.4 m

Inventories

(3.9 m)6.7 m3.1 m4.7 m(319 k)

Accounts Payable

(2.8 m)7.7 m(15.7 m)17.8 m1.5 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

11.7 m8.9 m9.7 m15.2 m15.2 m30.1 m44.1 m11.9 m26 m40 m15.5 m32.1 m

Depreciation and Amortization

19.9 m29.8 m11 m22.7 m34.4 m11.3 m22.1 m

Inventories

57 m58.2 m50.5 m1.4 m(1.4 m)1.3 m4 m5.5 m(5.6 m)(2 m)

Accounts Payable

21.8 m20.6 m20 m(9.8 m)(6.6 m)7.1 m3.6 m2.4 m(9.1 m)(7.6 m)
USDY, 2017

EV/CFO

27.5 x

EV/FCF

36.6 x

Revenue/Employee

561.1 k

Financial Leverage

1.6 x
Show all financial metrics

Balchem Corporation Operating Metrics

Balchem Corporation's Backlog was reported to be 26.2m in FY, 2016.
FY, 2015FY, 2016

Backlog

30.45 m26.20 m

Facilities

19

Patents Issued

109
Show all operating metrics
Report incorrect company information

Balchem Corporation News and Updates

Dietary Supplements in an Age of Personalized Nutrition Global Market 2018: Key Players – Maat Nutritionals, Natures Product Inc, Bactolac Pharmaceutical, Asiamerica Ingredients, Balchem Corporation

Dietary Supplements in an Age of Personalized Nutrition -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information